Ernal, Ethan Jay D.
HRN: 22-70-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/24/2023
03/30/2023
IVT
390mg
Q6
PCAP D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes